Found: 24
Select item for more details and to access through your institution.
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 33, p. 2801, doi. 10.1093/eurheartj/ehz299
- By:
- Publication type:
- Article
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).
- Published in:
- European Heart Journal, 2019, v. 40, n. 25, p. 2070, doi. 10.1093/eurheartj/ehy377
- By:
- Publication type:
- Article
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
- Published in:
- Current Atherosclerosis Reports, 2022, v. 24, n. 7, p. 585, doi. 10.1007/s11883-022-01025-7
- By:
- Publication type:
- Article
Quantification of Fatty Tissue Mass by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2005, v. 16, n. 3, p. 256, doi. 10.1046/j.1540-8167.2004.40498.x
- By:
- Publication type:
- Article
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2558, doi. 10.1111/bcp.14666
- By:
- Publication type:
- Article
Clinical Practice Guidelines and Scientific Evidence.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 301, n. 8, p. 831, doi. 10.1001/jama.2009.205
- By:
- Publication type:
- Article
Promises of PAR-1 Inhibition in Acute Coronary Syndrome.
- Published in:
- Current Cardiology Reports, 2012, v. 14, n. 1, p. 32, doi. 10.1007/s11886-011-0232-z
- By:
- Publication type:
- Article
Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 1, p. 82, doi. 10.1373/clinchem.2016.255208
- By:
- Publication type:
- Article
The Evolving Role of Glycoprotein IIb/IIIa Inhibitor Therapy in Contemporary Care of Acute Coronary Syndrome Patients.
- Published in:
- Journal of Interventional Cardiology, 2006, v. 19, n. 5, p. 449, doi. 10.1111/j.1540-8183.2006.00182.x
- By:
- Publication type:
- Article
Comparison of Clinical Trial Outcome Patterns in Patients Following Acute Coronary Syndromes and in Patients With Chronic Stable Atherosclerosis.
- Published in:
- Clinical Cardiology, 2014, v. 37, n. 6, p. 337, doi. 10.1002/clc.22255
- By:
- Publication type:
- Article
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 14
- By:
- Publication type:
- Article
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2018, v. 45, n. 4, p. 469, doi. 10.1007/s11239-018-1644-z
- By:
- Publication type:
- Article
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
- Published in:
- Catheterization & Cardiovascular Interventions, 2016, v. 88, n. 2, p. 163, doi. 10.1002/ccd.26335
- By:
- Publication type:
- Article
Stroke Risk Following Perioperative Atrial Fibrillation.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Trade-off ofmyocardial infarction vs. bleeding types onmortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
- Published in:
- European Heart Journal, 2017, v. 38, n. 11, p. 804, doi. 10.1093/eurheartj/ehw525
- By:
- Publication type:
- Article
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial.
- Published in:
- European Heart Journal, 2013, v. 34, n. 23, p. 1723, doi. 10.1093/eurheartj/eht104
- By:
- Publication type:
- Article
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article